| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |